Literature DB >> 22310797

Metastatic hepatocellular carcinoma presenting as facial nerve palsy and facial pain.

Jong In Yang1, Jung Mook Kang, Hee Jin Byun, Go Eun Chung, Jeong Yoon Yim, Min Jung Park, Jeong Hoon Lee, Jung Hwan Yoon, Hyo Suk Lee.   

Abstract

Facial nerve palsy due to temporal bone metastasis of hepatocellular carcinoma (HCC) has rarely been reported. We experienced a rare case of temporal bone metastasis of HCC that initially presented as facial nerve palsy and was diagnosed by surgical biopsy. This patient also discovered for the first time that he had chronic hepatitis B and C infections due to this facial nerve palsy. Radiation therapy greatly relieved the facial pain and facial nerve palsy. This report suggests that hepatologists should consider metastatic HCC as a rare but possible cause of new-onset cranial neuropathy in patients with chronic viral hepatitis.

Entities:  

Mesh:

Year:  2011        PMID: 22310797      PMCID: PMC3304660          DOI: 10.3350/kjhep.2011.17.4.319

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  11 in total

Review 1.  Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies.

Authors:  Erik Peitersen
Journal:  Acta Otolaryngol Suppl       Date:  2002

2.  An analysis of diagnostic delay in unilateral facial paralysis.

Authors:  A Alaani; R Hogg; N Saravanappa; R M Irving
Journal:  J Laryngol Otol       Date:  2005-03       Impact factor: 1.469

3.  Facial nerve palsy due to temporal bone metastasis from hepatocellular carcinoma.

Authors:  Michiaki Nagai; Hiroyasu Yamada; Mikiya Kitamoto; Junko Ikeda; Yoshiki Mori; Yoshio Monzen; Toshiyuki Fukuhara
Journal:  J Gastroenterol Hepatol       Date:  2005-07       Impact factor: 4.029

4.  Metastases to temporal bones from primary nonsystemic malignant neoplasms.

Authors:  T I Gloria-Cruz; P A Schachern; M M Paparella; G L Adams; S E Fulton
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-02

5.  Skull metastasis from hepatocellular carcinoma with chronic hepatitis B.

Authors:  Takashi Goto; Takahiro Dohmen; Kouichi Miura; Shigetoshi Ohshima; Kazuo Yoneyama; Tomomi Shibuya; Ei Kataoka; Daisuke Segawa; Wataru Sato; Yumiko Anezaki; Hajime Ishii; Daigo Kon; Ikuhiro Yamada; Kentaro Kamada; Hirohide Ohnishi
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

Review 6.  Isolated facial nerve palsy from metastasis to the temporal bone: report of two cases and a review of the literature.

Authors:  M D Weiss; J C Kattah; R Jones; H J Manz
Journal:  Am J Clin Oncol       Date:  1997-02       Impact factor: 2.339

Review 7.  Molecular targeting for treatment of advanced hepatocellular carcinoma.

Authors:  Il Han Song
Journal:  Korean J Hepatol       Date:  2009-09

Review 8.  Radiation therapy for hepatocellular carcinoma: from palliation to cure.

Authors:  Maria A Hawkins; Laura A Dawson
Journal:  Cancer       Date:  2006-04-15       Impact factor: 6.860

9.  Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors.

Authors:  Seung Up Kim; Do Young Kim; Jun Yong Park; Sang Hoon Ahn; Hyung Joong Nah; Chae Yoon Chon; Kwang-Hyub Han
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-16       Impact factor: 4.553

10.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

View more
  1 in total

1.  Retrobulbar metastasis and intracranial invasion from postoperative hepatocellular carcinoma: A case report and review of the literature.

Authors:  Chun-Yong Chen; Jian-Hong Zhong; Jing-Li Liu
Journal:  Oncol Lett       Date:  2014-11-24       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.